CYWC628
Wound Healing (Diabetic Foot Ulcers, Venous Leg Ulcers, burns)
Pre-clinicalActive
Key Facts
Indication
Wound Healing (Diabetic Foot Ulcers, Venous Leg Ulcers, burns)
Phase
Pre-clinical
Status
Active
Company
About FibroBiologics
FibroBiologics is developing a novel class of biologic treatments based on fibroblasts, one of the most abundant cells in the human body. The company claims its fibroblast platform offers superior potency, easier sourcing, and lower manufacturing costs compared to stem cell therapies. With over 270 patents and an IND-cleared program for degenerative disc disease, FibroBiologics is positioning itself as a leader in next-generation regenerative medicine.
View full company profile